Does AD26.COV2.S Cause Oedema peripheral? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Oedema peripheral have been filed in association with AD26.COV2.S. This represents 2.5% of all adverse event reports for AD26.COV2.S.
11
Reports of Oedema peripheral with AD26.COV2.S
2.5%
of all AD26.COV2.S reports
1
Deaths
10
Hospitalizations
How Dangerous Is Oedema peripheral From AD26.COV2.S?
Of the 11 reports, 1 (9.1%) resulted in death, 10 (90.9%) required hospitalization.
Is Oedema peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AD26.COV2.S. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does AD26.COV2.S Cause?
Covid-19 (58)
Fatigue (47)
Off label use (43)
Headache (42)
Pain (41)
Pyrexia (40)
Malaise (38)
Arthralgia (32)
Chills (31)
Nausea (25)
What Other Drugs Cause Oedema peripheral?
AMBRISENTAN (2,959)
TREPROSTINIL (2,816)
ADALIMUMAB (2,356)
LENALIDOMIDE (2,298)
AMLODIPINE (2,076)
PREDNISONE (2,029)
METHOTREXATE (1,939)
MACITENTAN (1,932)
RITUXIMAB (1,698)
TOCILIZUMAB (1,574)
Which AD26.COV2.S Alternatives Have Lower Oedema peripheral Risk?
AD26.COV2.S vs ADAGRASIB
AD26.COV2.S vs ADALIMUMAB
AD26.COV2.S vs ADALIMUMAB-AACF
AD26.COV2.S vs ADALIMUMAB-AATY
AD26.COV2.S vs ADALIMUMAB-ADAZ